Oncologix Tech, Inc. (OTCPK:OCLG) is seeking acquisitions. Wayne Erwin, OCLG's Chief Executive Officer, commented, "Our continued debt reduction strategy benefits the company in multiple ways including decreasing the continued downward pressure of our stock, reducing corporate debt, and improving our balance sheet and total net equity. This proactive activity combined with continued strategic acquisitions greatly increases our shareholders value."
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+177.17% | 6.65B | |
+2.10% | 981M | |
+5.75% | 928M | |
+41.91% | 872M | |
+22.08% | 804M | |
+1.91% | 664M | |
-.--% | 600M | |
-2.15% | 593M | |
+30.40% | 552M |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- OCLG Mulls Acquisitions